A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ann Eldred, MD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 105755
Aarhus N, Denmark
- Site Reference Id/investigator# 105757
Kolding, Denmark
- Site Reference Id/investigator# 105756
Odense C, Denmark
- Site Reference Id/investigator# 96295
Gainesville, Florida, United States
- Site Reference Id/investigator# 96778
Jacksonville, Florida, United States
- Site Reference Id/investigator# 96301
Tampa, Florida, United States
- Site Reference Id/investigator# 96302
Fort Wayne, Indiana, United States
- Site Reference Id/investigator# 101961
Indianapolis, Indiana, United States
- Site Reference Id/investigator# 103356
Boston, Massachusetts, United States
- Site Reference Id/investigator# 96303
Boston, Massachusetts, United States
- Site Reference Id/investigator# 96997
Grand Blanc, Michigan, United States
- Site Reference Id/investigator# 97878
Petoskey, Michigan, United States
- Site Reference Id/investigator# 99377
Royal Oak, Michigan, United States
- Site Reference Id/investigator# 99317
West Orange, New Jersey, United States
- Site Reference Id/investigator# 96996
New York, New York, United States
- Site Reference Id/investigator# 96296
Durham, North Carolina, United States
- Site Reference Id/investigator# 102020
Cleveland, Ohio, United States
- Site Reference Id/investigator# 103355
Columbus, Ohio, United States
- Site Reference Id/investigator# 97556
Pittsburgh, Pennsylvania, United States
- Site Reference Id/investigator# 103316
Providence, Rhode Island, United States
- Site Reference Id/investigator# 102019
Memphis, Tennessee, United States
- Site Reference Id/investigator# 108255
Charlottesville, Virginia, United States
- Site Reference Id/investigator# 96300
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2013
- Primary completion
- 31 May 2014
- Completion
- 31 May 2014
- Last update posted
- 6 Jun 2014
- Registered enrollment
- 56
- Registry id
- NCT01897519
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.